Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
J Int Migr Integr ; : 1-29, 2023 May 11.
Artículo en Inglés | MEDLINE | ID: mdl-37360632

RESUMEN

By the end of 2020, more than 500,000 migrants from Central America, Haiti, Africa, and Asia sought asylum along the US-Mexico border despite COVID-19-related travel restrictions and public health measures. A scoping review was conducted to understand the role of COVID-19-related policies on irregular migration flows through Central America and Mexico and to examine the experiences of asylum seekers traversing this region. Peer-reviewed literature, policy briefs, and commentaries were screened for inclusion, resulting in 33 documents selected for this review. This review identified three dominant themes: border closures due to multiple national migration policies, delays in asylum procedures, and increased risks to migrant wellbeing. This article argues that border closures were a punitive policy measure to deter irregular migration during the COVID-19 pandemic. Implications for future research and policy include prioritizing the health needs of asylum seekers and advocating the appropriateness and effectiveness of immigration and public health policy.

2.
J Transcult Nurs ; 31(4): 413-424, 2020 07.
Artículo en Inglés | MEDLINE | ID: mdl-32188342

RESUMEN

Introduction: Mental health mobile apps (MHapps) can provide depression treatment to people worldwide who do not have access to care, but few apps are culturally targeted to the population. In this series of studies, we described sociocultural considerations of MHapp development, and we explored participants' perceptions of acceptability, usability, and cultural relevance of the MHapp. Method: Individual interviews were conducted in three separate primary care sites in the Dominican Republic among convenience samples of staff and patients (n = 23, 18, and 21, respectively), using mixed methods of data collection. Results: Modifications were made during the iterative design process to reflect user preferences, which included a female gendered voice, the addition of animations, and changes to the psychoeducational content. Discussion: Primary care patients reported strong interest in MHapps due to its convenience, privacy, and affordability. Our findings support the necessity of detailed examination of user preferences to develop culturally congruent MHapp psychoeducation.


Asunto(s)
Adaptación Psicológica , Depresión/prevención & control , Aplicaciones Móviles/normas , Pobreza/psicología , Adulto , Terapia Cognitivo-Conductual/métodos , Terapia Cognitivo-Conductual/normas , Terapia Cognitivo-Conductual/tendencias , Depresión/psicología , República Dominicana , Femenino , Humanos , Masculino , Aplicaciones Móviles/tendencias , Pobreza/tendencias , Atención Primaria de Salud/métodos , Atención Primaria de Salud/normas , Diseño Centrado en el Usuario
3.
Acta Pharm ; 66(3): 443-8, 2016 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-27383892

RESUMEN

The study tested the hypothesis that cerebrolysin protects the brain from free radicals in rats treated with 3-nitropropionic acid (3-NPA). To address this hypothesis, the levels of dopamine (DA) and some oxidative stress biomarkers were measured after administration of 3-NPA. Young male Fischer rats were treated for three days with cerebrolysin, 3-NPA or both substances. Their brains were extracted, and DA, lipid peroxidation (LP), glutathione (GSH), calcium, and H2O2 were measured using validated methods. In the cortex, hemispheres and cerebellum/medulla oblongata of the group treated with cerebrolysin and 3-NPA, the levels of DA and LP decreased. In addition, calcium and H2O2 levels decreased in the hemispheres of the same group, while GSH increased in cortex. The increased dopamine metabolism due to the administration of cerebrolysin led to increased formation of radical species and oxidative stress, especially when free radicals were generated by 3-NPA.


Asunto(s)
Aminoácidos/uso terapéutico , Antioxidantes/uso terapéutico , Neuronas Dopaminérgicas/efectos de los fármacos , Enfermedades Neurodegenerativas/prevención & control , Fármacos Neuroprotectores/uso terapéutico , Síndromes de Neurotoxicidad/prevención & control , Estrés Oxidativo/efectos de los fármacos , Aminoácidos/efectos adversos , Animales , Antioxidantes/efectos adversos , Calcio/metabolismo , Corteza Cerebelosa/efectos de los fármacos , Corteza Cerebelosa/metabolismo , Cerebelo/efectos de los fármacos , Cerebelo/metabolismo , Cerebro/efectos de los fármacos , Cerebro/metabolismo , Convulsivantes/efectos adversos , Dopamina/metabolismo , Neuronas Dopaminérgicas/metabolismo , Glutatión/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Masculino , Bulbo Raquídeo/efectos de los fármacos , Bulbo Raquídeo/metabolismo , Enfermedades Neurodegenerativas/inducido químicamente , Enfermedades Neurodegenerativas/metabolismo , Fármacos Neuroprotectores/efectos adversos , Síndromes de Neurotoxicidad/metabolismo , Nitrocompuestos/efectos adversos , Propionatos/efectos adversos , Ratas Endogámicas F344
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA